UK sees 17% surge in medical device trials as brain tech takes off
Regulators fast-track approvals while neurotechnology studies double, putting Britain at center of global health innovation race
H1 and Novo Nordisk partner to accelerate clinical trials with AI
The deal gives H1 rights to StudyHub, Novo Nordisk's in-house clinical development platform, and signals a broader shift in how pharma is approaching trial design